OPEN END INDEX-CERTIFICATE - AMGEN Share Price

Certificat

8F99S

FRSGE001LDE4

Market Closed - Euronext Paris 01:34:23 29/05/2024 BST
0.91 ^EUR	0.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Chart OPEN END INDEX-CERTIFICATE - AMGEN

Latest news about AMGEN INC.

US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	05-28	RE
Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval	05-28	DJ
Weight-loss drug forecasts jump to $150 billion as supply grows	05-28	RE
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies	05-27	AQ

More news

Static data

Product type	Certificats Index
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Société Générale
	8F99S
ISIN	FRSGE001LDE4
Date issued	25/04/2023
Maturity	Unlimited
Parity	1 : 1
Emission price	0.91 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company